rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Actuate Therapeutics, Inc.

ACTU · Nasdaq

Health CareBiotechnologyNot moving yet

ACTU stood above a rising 150-day average in 0 of the last 52 weekly readings. It is 64.8% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 52
Industry in uptrend
15% -17 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$3.2M
Officials’ trades on record
0
Institutions holding
63 (+3)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 0 of 52 weeks.

17 Apr – 16 Oct
16%28%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$3.1M$0$1.3MNov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0
Sale orders, 12 months1
Buyers · sellers0 · 1
WhoDidSharesTraded
Todd S. ThomsonDirector, 10% ownersold280,000at $5.805 Jan 2026filed 7 Jan 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders63+3 on the quarter
New · exited18 · 15
Reported value$20.6M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
BIOS Capital Management, LPunchanged · filed 14 Aug 202610,049,996$15.4M00.0%
Voss Capital, LPunchanged · filed 14 Aug 20261,725,000$2.6M00.0%
VANGUARD CAPITAL MANAGEMENT LLCreduced · filed 13 Aug 2026393,433$602K-7,096−1.8%
AQR CAPITAL MANAGEMENT LLCadded · filed 14 Aug 2026127,493$195K+100,384+370.3%
GEODE CAPITAL MANAGEMENT, LLCreduced · filed 12 Aug 2026112,554$172K-115,777−50.7%
Texas Capital Bank Wealth Management Services Incadded · filed 7 Aug 2026102,612$157K+8,020+8.5%
Palogic Value Management, L.P.unchanged · filed 14 Aug 2026100,000$153K00.0%
MILLENNIUM MANAGEMENT LLCnew · filed 14 Aug 202696,684$148K+96,684
BlackRock, Inc.reduced · filed 7 Aug 202690,035$138K-337,118−78.9%
ABS Investment Management LLCnew · filed 14 Aug 202673,186$112K+73,186
30 Sep 2024 – 30 Jun 2026
123761Sep 24Mar 25Sep 25Dec 25Jun 26

News

No headline names it lately.

Everyone who traded it

Daniel M. Schmitt Company insiderPresident, CEO and Director · last 14 Aug 20260 · 0
Aaron G.L. Fletcher Company insiderDirector, 10% owner · last 21 May 20260 · 0
Amy L. Ronneberg Company insiderDirector · last 21 May 20260 · 0
Dan Zabrowski Company insiderDirector · last 21 May 20260 · 0
Jason A. Keyes Company insiderDirector · last 21 May 20260 · 0
Martin H. Huber Jr. Company insiderDirector · last 21 May 20260 · 0
Roger Sawhney Company insiderDirector · last 21 May 20260 · 0
Todd S. Thomson Company insiderDirector, 10% owner · last 21 May 20260 · 1
Andrew Paul Mazar Company insiderChief Operating Officer · last 1 Apr 20260 · 0
Paul J. Lytle Company insiderChief Financial Officer · last 1 Apr 20260 · 0
Bios Actuate Co-Invest I, Lp Company insiderDirector, 10% owner · last 27 Jun 20251 · 0
Bios Equity Cof, Lp Company insiderDirector, 10% owner · last 27 Jun 20251 · 0

Same industry

MRNA ModernaLeading+147%
ENTX Entera BioLeading+37%
XNCR XencorLeading+30%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Share count trendFY 2025 · to 25 Mar 20262.0%
Cash and equivalentsFY 2025 · to 31 Dec 2025$13.2M

Analyst forecasts

No analyst forecasts yet.